The British Journal of Nutrition · Nov 19, 2026
Effects of synbiotic supplementation on serum lipids, lipoproteins and blood pressure in kidney transplant recipients with overweight or obesity: a randomised controlled trial
By Karimi Z, Tabibi H, Nafar M et al.
Lipid abnormalities and hypertension are prevalent in kidney transplant (KT) recipients. This research aimed to assess the impact of synbiotic supplementation on serum lipid levels, lipoproteins and blood pressure among KT recipients with overweight or obesity. In this randomised controlled trial, forty-six KT recipients were allocated randomly to either the synbiotic group or the placebo group. Those in the synbiotic group received two capsules containing synbiotics daily for a duration of 12 weeks, whereas the placebo group was given an equivalent placebo. Serum levels of total cholesterol, TAG, LDL-cholesterol, HDL-cholesterol and lipoprotein (a) [Lp(a)], along with systolic and diastolic blood pressure were measured. The results indicated significant reductions in serum total cholesterol ( P = 0·022; effect size= −0·75), LDL-cholesterol ( P = 0·037; effect size: −0·68) and systolic blood pressure ( P = 0·034; effect size: −0·74) in the synbiotic group compared with the placebo group. Additionally, serum TAG ( P = 0·048; effect size: −0·44) and diastolic blood pressure ( P = 0·001; effect size: −1·04) showed significant decreases by week 12 relative to baseline measurements within the synbiotic group. However, there were no significant changes in serum HDL-cholesterol and Lp(a) for either group throughout the study period. Overall, this study indicated that synbiotic supplementation reduces total serum cholesterol, LDL-cholesterol, TAG and both systolic and diastolic blood pressure in KT recipients.